|
FAM169A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.17919999612582E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.5305999991393E-08 |
| Normal-vs-Stage2 |
4.93099999721025E-08 |
| Normal-vs-Stage3 |
3.52650000312593E-08 |
| Normal-vs-Stage4 |
1.9030000020237E-08 |
| Stage1-vs-Stage2 |
6.045400E-01 |
| Stage1-vs-Stage3 |
3.876600E-01 |
| Stage1-vs-Stage4 |
1.342020E-01 |
| Stage2-vs-Stage3 |
9.629600E-01 |
| Stage2-vs-Stage4 |
6.026400E-01 |
| Stage3-vs-Stage4 |
6.182400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.9484999976055E-08 |
| Normal-vs-AfricanAmerican |
7.31120000097008E-08 |
| Normal-vs-Asian |
1.757900E-02 |
| Caucasian-vs-AfricanAmerican |
8.518800E-01 |
| Caucasian-vs-Asian |
3.064200E-01 |
| AfricanAmerican-vs-Asian |
2.050400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.09680000531998E-08 |
| Normal-vs-Female |
5.33320000051241E-07 |
| Male-vs-Female |
6.123900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.2750999995047E-07 |
| Normal-vs-Extreme_Weight |
5.29200000487506E-08 |
| Normal-vs-Obese |
4.00459999605474E-08 |
| Normal-vs-Extreme_Obese |
5.49159999696514E-08 |
| Normal_Weight-vs-Extreme_Weight |
4.112400E-01 |
| Normal_Weight-vs-Obese |
2.456000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.896400E-01 |
| Extreme_Weight-vs-Obese |
7.900400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.126600E-01 |
| Obese-vs-Extreme_Obese |
6.379600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.47459999988442E-07 |
| Normal-vs-Age(41-60Yrs) |
7.96610000186604E-08 |
| Normal-vs-Age(61-80Yrs) |
6.60100000215991E-08 |
| Normal-vs-Age(81-100Yrs) |
1.17559999512906E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.033000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.005400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.333030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.323800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.319700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.693800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.37689999799318E-08 |
| Normal-VS-Type2 PRCC |
3.93639999485274E-08 |
| Normal-VS-KIRP CIMP |
1.09000000136916E-08 |
| Normal-VS-Unclassified PRCC |
1.10080000004231E-07 |
| Type1 PRCC-VS-Type2 PRCC |
9.880600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.820000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.749000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.878370E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.099600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.463610E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.907300008687E-09 |
| Normal-vs-N1 |
3.98360000541942E-08 |
| Normal-vs-N2 |
4.23369994617673E-09 |
| N0-vs-N1 |
2.074000E-01 |
| N0-vs-N2 |
6.339900E-02 |
| N1-vs-N2 |
3.714200E-02 |
|
|
